Dodolan perusahaan mdxhealth.com (MDXH)

Increasing demand for ConfirmMDx tests in urology is driving current revenue, as evidenced by the sales levels of MDxHealth SA (MDXH). The latest figure remains around 0.11. While high scientific and technical potential in oncology DNA marker analysis is underpinned by R&D investments, aggressive competition for insurance contracts with large-scale laboratories is exerting significant pressure on the business's financial results.

mdxhealth.com - Dodolan perusahaan MDXH (periode 04.07.2022 - 13.11.2026)

Rincian metrik komprehensif lan analitis MDxHealth (MDXH)

- nilai pasar lan prakiraan target analis:

Bagan bursa MDxHealth, Inc.|MDXH - Bagan rega target

- rincian kapitalisasi pasar:

Biji pasar MDxHealth|MDXH - Nilai Perusahaan

- data ekuitas miturut neraca:

Ekuitas saben Saham MDxHealth SA|MDXH - Aset Bersih Perusahaan|Rasio Kapitalisasi marang Nilai Buku mdxhealth.com|MDXH - Total Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Rasio Kabeh Utang marang Dana Pribadi MDxHealth SA|MDXH - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal MDxHealth S.A.|MDXH - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku MDxHealth|MDXH - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan MDxHealth SA|Rasio likuiditas perantara mdxhealth.com

- rincian asil keuangan lan kelipatan valuasi:

MDXH - Bathi resik|Penghasilan resik sing dikarepake MDxHealth SA|MDXH - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi mdxhealth.com|MDXH - Rasio rega marang bathi tumrap wutah|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan MDxHealth|MDXH - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) MDxHealth SA|MDXH - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan mdxhealth.com|MDXH - Wutah bathi ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep MDxHealth SA

- rincian pendapatan lan dodolan emiten:

MDXH - Dodolan perusahaan|Prakiraan pendapatan perusahaan MDxHealth, Inc.|MDXH - Multiplikator P/S|Rega forward marang dodolan MDxHealth

Ringkesan analisis perusahaan:MDXH, MDxHealth, Inc.

Investors are verifying the reliability of MDxHealth SA (MDXH) through an analysis of revenue dynamics and estimated multiples. The company's sales performance reflects the daily volume of proceeds from the sale of molecular tests. This metric measures real cash flow, capturing the phases of the economic cycle. Growth in this indicator confirms the efficiency of centralized test processing, which reduces unit costs. The positive trend on the chart demonstrates the scalability of the biopharmaceutical business.

Analisis perusahaan pesaing